Impact of Vitiligo on Quality of Life in Patients of Skin of Color and Its Correlation With Clinical Severity Assessment Scores Utilizing Disease Specific Scores: a Cross-Sectional Study

Guneet  Awal; Navleen Kaur; Guramrit Singh; Nishant Sharma

doi:10.5826/dpc.1402a75

Impact of Vitiligo on Quality of Life in Patients of Skin of Color and Its Correlation With Clinical Severity Assessment Scores Utilizing Disease Specific Scores: a Cross-Sectional Study

Authors

Guneet Awal Department of Dermatology,Venereology and Leprosy, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India
Navleen kaur Department of Dermatology,Venereology and Leprosy, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India
Guramrit Singh Department of Dermatology,Venereology and Leprosy, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India
Nishant Sharma Department of Community Medicine, Sri Guru Ram Das Institute of Medical Sciences and Research, Amritsar, India

Keywords:

Vitiligo, Quality of life, Skin of color, VIS-22, VitiQoL

Abstract

Introduction: Assessment of disease severity of vitiligo is exigent as it is a psychosomatic ailment. VIDA (vitiligo disease activity score) and VASI (vitiligo area severity index) were previously used for this evaluation. Recently, the introduction of two vitiligo specific tools, vitiligo impact scale (VIS)-22 and Vitiligo Quality of Life Index (VitiQoL) has aided in assessing the quality of life (QOL) in a pertinent manner.

Objectives: To measure the QOL in vitiligo using disease specific indices (VitiQoL and VIS-22), to assess their relationship with disease severity (VASI and VIDA) and to determine the correlation between QOL scores (VIS-22 and VitiQoL).

Methods: This observational cross-sectional study included 195 patients with vitiligo, and their disease severity was calculated using VASI and VIDA scoring. Patients were asked to fill questionnaires for assessing the QOL using validated tools ie VIS-22 and VitiQoL.

Results: Significant correlation was demonstrated between both QOL scores and VASI score (P value 0.001) with slightly higher values for VitiQoL (r = 0.824) than with VIS 22 (r = 0.693). Both scores exhibited a significant association with VIDA score (P value < 0.001). Moreover, statistically significant correlation was found between VIS-22 and VitiQoL, thereby proving the concordance between these scores.

Conclusions: The study infers that QOL seemed to be remarkably dependent on the clinical severity scores and that higher disease activity corresponds to poorer QOL. It is imperative to precisely assess burden of vitiligo and the impairments caused by it in order to aid multi-modality management and allow more standardized research.

References

Njoo MD, Westerhof W. Vitiligo pathogenesis and treatment. Am J Clin Dermatol. 2001;2(3):167-181. DOI: 10.2165/00128071-200102030-00006. PMID: 11705094.

Parsad D, Dogra S, Kanwar AJ. Quality of life in patients with vitiligo. Health Qual Life Outcomes. 2003;1:58. DOI: 10.1186/1477-7525-1-58. PMID: 14613564. PMCID: PMC269995.

Amer AA, Gao XH. Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades. Int J Dermatol. 2016;55(6):608-614. DOI: 10.1111/ijd.13198. PMID: 26749040.

Malhotra N, Dytoc M. The pathogenesis of vitiligo. J Cutan Med Surg. 2013;17(3):153-172. DOI: 10.2310/7750.2012.12005. PMID: 23673299.

Hamzavi I, Jain H, McLean D, Shapiro J, Zeng H, Lui H. Parametric modeling of narrowband UV-B phototherapy for vitiligo using a novel quantitative tool: the Vitiligo Area Scoring Index. Arch Dermatol. 2004;140(6):677-683. DOI: 10.1001/archderm.140.6.677. PMID: 15210457.

Njoo MD, Das PK, Bos JD, Westerhof W. Association of the Koebner phenomenon with disease activity and therapeutic responsiveness in Vitiligo Vulgaris. Arch Dermatol. 1999;135(4):407-413. DOI: 10.1001/archderm.135.4.407. PMID: 10206047.

Mattoo SK, Handa S, Kaur I, Gupta N, Malhotra R. Psychiatric morbidity in vitiligo: prevalence and correlates in India. J Eur Acad Dermatol Venereol. 2002;16(6):573-857. DOI: 10.1046/j.1468-3083.2002.00590.x. PMID: 12482039.

Porter JR, Beuf AH, Lerner A, Nordlund J. Psychosocial effect of vitiligo: a comparison of vitiligo patients with ‘‘normal’’ control subjects, with psoriasis patients, and with patients with other pigmentary disorders. J Am Acad Dermatol. 1986;15(2 Pt 1):220-224. DOI: 10.1016/s0190-9622(86)70160-6. PMID: 3745526.

Wang KY, Wang KH, Zhang ZP. Health-related quality of life and marital quality of vitiligo patients in China. J Eur Acad Dermatol Venereol. 2011;25(4):429-435. DOI: 10.1111/j.1468-3083.2010.03808.x. PMID: 20666878.

Talsania N, Lamb B, Bewley A. Vitiligo is more than skin deep: a survey of members of the Vitiligo Society. Clin Exp Dermatol. 2010;35(7):736-739. DOI: 10.1111/j.1365-2230.2009.03765.x. PMID: 20015281.

Kent G, al-Abadie M. Factors affecting responses on Dermatology Life Quality Index items among vitiligo sufferers. Clin Exp Dermatol. 1996;21(5):330-333. PMID: 9136149.

Gupta V, Sreenivas V, Mehta M, Khaitan BK, Ramam M. Measurement properties of the Vitiligo Impact Scale-22 (VIS-22), a vitiligo-specific quality-of-life instrument. Br J Dermatol. 2014;171(5):1084-1090. DOI: 10.1111/bjd.13093. PMID: 24805089.

Hedayat K, Karbakhsh M, Ghiasi M, et al. Quality of life in patients with vitiligo: a cross-sectional study based on Vitiligo Quality of Life index (VitiQoL). Health Qual Life Outcomes. 2016;14:86. DOI: 10.1186/s12955-016-0490-y. PMID: 27267598. PMCID: PMC4897932.

Lilly E, Lu PD, Borovicka JH, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11-e18. DOI: 10.1016/j.jaad.2012.01.038. PMID: 22365883.

Krishna GS, Ramam M, Mehta M, Sreenivas V, Sharma VK, Khandpur S. Vitiligo impact scale: An instrument to assess the psychosocial burden of vitiligo. Indian J Dermatol Venereol Leprol. 2013;79(2):205-210. DOI: 10.4103/0378-6323.107637. PMID: 23442459.

Gupta V, Sreenivas V, Mehta M, Ramam M. What do Vitiligo Impact Scale-22 scores mean? Studying the clinical interpretation of scores using an anchor-based approach. Br J Dermatol. 2019;180(3):580-585. DOI: 10.1111/bjd.17040. PMID: 30085349.

Agarwal S, Jain C, Shaafie HI, Khalid A, Singh A. Impact on quality of life of family members of vitiligo patients in North India: A cross-sectional study using family dermatology life quality index. Indian J Dermatol Venereol Leprol. 2021;87(6):869-872. DOI: 10.25259/IJDVL_933_20. PMID: 34672480.

Kim DY, Lee JW, Whang SH, Park YK, Hann SK, Shin YJ. Quality of life for Korean patients with vitiligo: Skindex-29 and its correlation with clinical profiles. J Dermatol. 2009;36(6):317-322. DOI: 10.1111/j.1346-8138.2009.00646.x. PMID: 19500179.

Kostopoulou P, Jouary T, Quintard B, et al. Objective vs. subjective factors in the psychological impact of vitiligo: the experience from a French referral centre. Br J Dermatol. 2009;161(1):128-133. DOI: 10.1111/j.1365-2133.2009.09077.x. PMID: 19298280.

Borimnejad L, Parsa Yekta Z, Nikbakht-Nasrabadi A, Firooz A. Quality of life with vitiligo: comparison of male and female muslim patients in Iran. Gend Med. 2006;3(2):124-130. DOI: 10.1016/s1550-8579(06)80201-9. PMID: 16860271.

Hammam MA, Yasien HA, Algharably AF. Effect of Vitiligo Area Scoring Index on the quality of life in patients with vitiligo. Menoufia Med J. 2019;32:244-249. DOI: 10.4103/mmj.mmj_399_17.

Aghaei S, Sodaifi M, Jafari P, Mazharinia N, Finlay AY. DLQI scores in vitiligo: reliability and validity of the Persian version. BMC Dermatol. 2004;4:8. DOI: 10.1186/1471-5945-4-8. PMID: 15294022. PMCID: PMC514558.

Patvekar MA, Deo KS, Verma S, Kothari P, Gupta A. Quality of life in vitiligo: Relationship to clinical severity and demographic data. Pigment Int. 2017;4:104-108. DOI: 10.4103/2349-5847.219684.

Kota RS, Vora RV, Varma JR, Kota SK, Patel TM, Ganjiwale J. Study on Assessment of Quality of Life and Depression in Patients of Vitiligo. Indian Dermatol Online J. 2019;10(2):153-157. DOI: 10.4103/idoj.IDOJ_14_18. PMID: 30984590. PMCID: PMC6434757.

Dolatshahi M, Ghazi P, Feizy V, Hemami M. Life quality assessment among patients with vitiligo: Comparison of married and single patients in Iran. Indian J Dermatol Venereol Leprol. 2008;74(6):700. DOI: 10.4103/0378-6323.45141. PMID: 19177700.

Do Bú EA, Alexandre MES, Scardua A, Araújo CRF. Vitiligo as a psychosocial disease: apprehensions of patients imprinted by the white. Interface - Comunicação, Saúde, Educação. 2018;22(65):481-491. DOI: 10.1590/1807-57622016.0925.

Simons RE, Zevy DL, Jafferany M. Psychodermatology of vitiligo: Psychological impact and consequences. Dermatol Ther. 2020;33(3):e13418. DOI: 10.1111/dth.13418. PMID: 32297399.

Radtke MA, Schäfer I, Gajur A, Langenbruch A, Augustin M. Willingness-to-pay and quality of life in patients with vitiligo. Br J Dermatol. 2009;161(1):134-139. DOI: 10.1111/j.1365-2133.2009.09091.x. PMID: 19298268.

Linthorst Homan MW, Spuls PI, de Korte J, Bos JD, Sprangers MA, van der Veen JP. The burden of vitiligo: patient characteristics associated with quality of life. J Am Acad Dermatol. 2009;61(3):411-420. DOI: 10.1016/j.jaad.2009.03.022. PMID: 19577331.

Choi S, Kim DY, Whang SH, Lee JH, Hann SK, Shin YJ. Quality of life and psychological adaptation of Korean adolescents with vitiligo. J Eur Acad Dermatol Venereol. 2010;24(5):524-529. DOI: 10.1111/j.1468-3083.2009.03452.x. PMID: 19807826.

Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473-491. DOI: 10.1016/j.jaad.2010.11.061. PMID: 21839315.

Al-Mubarak L, Al-Mohanna H, Al-Issa A, Jabak M, Mulekar SV. Quality of life in Saudi vitiligo patients. J Cutan Aesthet Surg. 2011;4(1):33-37. DOI: 10.4103/0974-2077.79188. PMID: 21572679 PMCID: PMC3081482.

Belgaumkar VC,, Ravindranath D, Nupur NW. . Impact of Vitiligo on Quality of Life: A Cross-sectional Pilot Study from Western India. Journal of Skin and Stem Cell. 2020;7. DOI: 10.5812/jssc.107184.

Mechri A, Amri M, Douarika AA, Ali Hichem BH, Zouari B, Zili J. Morbidite psychiatrique et qualite de vie des patients atteints du vitiligo: etude cas-temoins [Psychiatric morbidity and quality of life in Vitiligo: a case controlled study]. Tunis Med. 2006;84(10):632-635. PMID: 17193855.

Karelson M, Silm H, Kingo K. Quality of life and emotional state in vitiligo in an estonian sample: Comparison with psoriasis and healthy controls. Acta Derm Venereol. 2013;93(4):446-450. DOI: 10.2340/00015555-1520. PMID: 23306792.

Sangma LN, Nath J, Bhagabati D. Quality of life and psychological morbidity in vitiligo patients: a study in a teaching hospital from north-East India. Indian J Dermatol. 2015;60(2):142-146. DOI: 10.4103/0019-5154.152508. PMID: 25814701. PMCID: PMC4372905.

Silverberg JI, Silverberg NB. Association between vitiligo extent and distribution and quality-of-life impairment. JAMA Dermatol. 2013;149(2):159-164. DOI: 10.1001/jamadermatol.2013.927. PMID: 23560296.